London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Not really, RSP for 100k is a joke - 90p - £1.0865 [same as yesterday.
They move the bid 5% in a flash
Wide spread, buy at 98.4 and seel at 95.5.
Can sell a few now at 95.5! Jeez what a game AIM is. This was only going one way and that was up and now the tide has changed. Too many cheap shares on sale?
Yes, very strange, now can sell around 95.
Swlc
I had that yesterday too. Couldn’t sell but buy, but in the same day I also couldn’t buy but easily sell everything in one go.
Strange happenings.
Can not sell but can buy, are new shares been dumped into market now?
Thanks for response Saf.
I don't think we could find a better pair of hands to deliver extreme Shareholder Value. highly motivated and knows how the City works:
Gabriele M. Cerrone is the Executive Chairman of the company. Mr. Cerrone has a successful track record and extensive experience in the financing and restructuring of micro-cap biotechnology companies. He has founded nine biotechnology companies in oncology, infectious diseases and molecular diagnostics, and has taken six of these companies to the Nasdaq Market and one to the AIM Market in London. Mr. Cerrone co-founded Trovagene, Inc., a molecular diagnostic company and served as its Co-Chairman; he was a co-founder and served as Chairman of both Synergy Pharmaceuticals, Inc. and Callisto Pharmaceuticals, Inc., and was a Director of and led the restructuring of Siga Technologies, Inc. Mr. Cerrone also co-founded FermaVir Pharmaceuticals, Inc. and served as Chairman of the Board until its merger in September 2007 with Inhibitex, Inc. Mr. Cerrone served as a director of Inhibitex, Inc. until its US$2.5bn sale to Bristol Myers Squibb Co in 2012. Mr. Cerrone is the Executive Chairman and Co-Founder of Gensignia Life Sciences, Inc., a molecular diagnostics company focused on oncology using microRNA technology; Chairman and Founder of Tiziana Life Sciences plc an oncology focused therapeutics company; Chairman and Co-Founder of Rasna Therapeutics Limited, a company focused on the development of therapeutics for leukaemias; Co-Founder of ContraVir Pharmaceuticals, Inc. and founder of BioVitas Capital Ltd.
Gabriele M. Cerrone
Founder of 9 different companies, notably: Tiziana Life Sciences Plc, Hepion Pharmaceuticals, Inc. and FermaVir Pharmaceuticals, Inc. Gabriele Marco Antonio Cerrone is an Italian entrepreneur and businessperson who has been the head of 10 different companies and currently occupies the position of Executive Chairman of Tiziana Life Sciences Plc (which he founded in 2013), Executive Chairman of Gensignia Ltd. (which he founded), Chairman at Arna Therapeutics Ltd. (which he founded), Chairman of Biovitas Capital Ltd. (which he founded), Executive Chairman at Gensignia Life Sciences, Inc. (which he founded) and Managing Partner at Panetta Partners Ltd. Mr. Cerrone is also on the board of Gensignia IP Ltd.
In his past career he held the position of Co-Chairman for TrovaGene, Inc. (he founded the company in 1999), Managing Director-Investments at Barrington Capital Group LP, Chairman at Callisto Pharmaceuticals, Inc., Chairman at FermaVir Pharmaceuticals, Inc. (he founded the company in 2007), Chairman for Synergy Pharmaceuticals LLC, Chairman for Rasna Therapeutics, Inc. (he founded the company in 2013) and Senior Vice President-Investments at Oppenheimer & Co., Inc.
Mr. Cerrone received a graduate degree from New York University.
Y-Alam
Even if Tils gets taken over on a lower price, there are no secrets in this market. There will be huge buy ins and no speeding tickets can be issued because we all know what’s around the corner.
The way the money is bouncing around the pharmas i expect 3 digit increases on the day easily. Or it’ll open gap up, but with a significant gap.
Everyone can and should relax, TILS is in for very good ride. The platform is solid, the 4 drivers are game changers, first out the blocks is STEM which is about to fly, think Space X! Two more products in the pipeline are going to be game changers, news is imminent so hang in there....do you think a number of highly credible publications and stock pickers would put a £5 target price by the end of this year without have done extensive research! I doubt they would gamble their credibility so easily. I have good insight into this research and without doubt this is going to be the best AIM Stock of 2020!
Enough said for now.
.....Gabriele said in the last interview that they are working “aggressively “ on spinning off StemPrintER
Y-Alan
Check the ceo's cv i suspect he very much knows what he's doing :-)
This is why the split will happen very soon imo .
Asher that is my worry too. The longer it stays in this range and the longer they take to demerge Stem the more risk of takeover at a lower price.
Going be a fine balance for the CEO and he's got be careful he doesn't mute the sp and market cap to much,really don't want to be taken out for peanut.
The spilt is going to happen a lot sooner than some think imo
Dont think warrant holders will be selling, I think they have seen an opportunity, exercised their warrants, sold a few to pay for holding and will hold rest. No risk.
Man, to be honest suprised we did not Gap up to the Nasdaq close. The ATM facility will deter traders due to the fear of constant dilution furthermore the overhang has muted any sp rise and will keep the sp down. If you have done your research you should not be worried. This will rise eventually.
How can they be clearing stock that hasnt even been sold or issued yet. The ATM facilities is used IF and when needed.
New overhang is the warrant holders selling. aimho
Lots of buying. MMs lowering the price merely giving people the chance to get in cheaper, and they are taking it. If appetite continues this will quickly go blue.